Salarius Pharmaceuticals Inc. buy melinda
Start price
15.04.17
/
50%
€49,892
Target price
27.04.17
€57,784
Performance (%)
9.04%
End price
27.04.17
€54,402
Summary
This prediction ended on 27.04.17 with a price of €54,402. With a performance of 9.04%, the BUY prediction by melinda for Salarius Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.410% | -2.543% | 14.415% | 14.709% |
| iShares Nasdaq 100 | -2.154% | 4.721% | 33.222% | 52.436% |
| iShares Nikkei 225® | -0.066% | -0.307% | 8.496% | 3.743% |
| iShares S&P 500 | -0.527% | 3.848% | 28.621% | 47.348% |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€51,442
12.06.17
12.06.17
€57,784
21.06.17
21.06.17
14.25%
21.06.17
21.06.17
